Abstract
Twelve antagonists of apomorphine-induced emesis in dogs were studied in different tests to evaluate their antiemetic specificity. Ten of these antagonists were neuroleptics: benzquinamide, clebopride, bromopride, prochlorperazine, haloperidol, chlorpromazine, thiethylperazine, metoclopramide, droperidol, and pimozide blocked conditioned responding in dogs and apomorphine-induced stereotyped behavior in rats. The use of these compounds as anti-emetics entails a risk of neurological side effects. Metopimazine and domperidone were devoid of neuroleptic activity. Metopimazine, however, showed potent α-adrenergic blocking activity, showed histamine H1 antagonism, and induced palpebral ptosis. Therapeutic doses of metopimazine are, therefore, likely to produce sedation and side-effects related to autonomic blockade. Domperidone showed potent antiemetic activity and, up to high doses, no other central or peripheral effects. Therefore, domperidone is the only specific antiemetic known.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Awouters F, Niemegeers CJE, Janssen PAJ (1981) Inhibitors of mast cell-mediated shock in the rat: Relationship to histamine and serotonin antagonism. Drug Dev Res 1:107–114
Finney DJ (1962) Probit analysis. Cambridge University Press, Cambridge, pp 238–254
Janssen PAJ, Niemegeers CJE, Schellekens KHL (1965) Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? I. Neuroleptic activity spectra for rats. Arzneim Forsch 15:104–117
Janssen PAJ, Niemegeers CJE, Schellekens KHL, Dresse A, Lenaerts FM, Pinchard A, Schaper WKA, Van Nueten JM, Verbruggen FJ (1968) Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. I. The comparative pharmacology of pimozide, haloperidol and chlorpromazine. Arzneim Forsch 18:261–279
Niemegeers CJE, Janssen PAJ (1960) Influence of haloperidol (R-1625) and of haloperidol (R-3201) on avoidance and escape behaviour of trained dogs in a jumping box. J Pharm Pharmacol 12:744–753
Niemegeers CJE, Janssen PAJ (1979) A systematic study of the pharmacological activities of dopamine antagonists. Life Sci 24:2201–2216
Niemegeers CJE, Awouters F, Van Nueten JM, De Nollin S, Janssen PAJ (1978) Protection of rats from compound 48/80-induced lethality. A simple test for inhibitors of mast cell-mediated shock. Arch Int Pharmacodyn Ther 234:164–176
Niemegeers CJE, Lenaerts FM, Artois KSK, Janssen PAJ (1977) Interaction of drugs with apomorphine, tryptamine and norepinephrine. A new in vivo approach: The ATN-test in rats. Arch Int Pharmacodyn Ther 227:288–254
Niemegeers CJE, Schellekens KHL, Janssen PAJ (1980) The antiemetic effects of domperidone, a novel potent gastrokinetic. Arch Int Pharmacodyn Ther 244:130–140
Tedeschi DH, Tedeschi RE, Fellows ES (1959) The effects of tryptamine on the central nervous system, including a pharmacological procedure for the evaluation of iproniazid-like drugs. J Pharmacol Exp Ther 126:223–232
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Niemegeers, C.J.E. Antiemetic specificity of dopamine antagonists. Psychopharmacology 78, 210–213 (1982). https://doi.org/10.1007/BF00428152
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00428152